The Autism Biomarkers Consortium for Clinical Trials: Confirmation Study (ABC-CT CS)
To see if eye tracking (ET) or electroencephalogram (EEG) assessments have potential use in future clinical trials of Autism Spectrum Disorders (ASD).
CHLA IRB Number
CHLA-22-00055
Eligibility
Families with children between the ages of 6-11 years old, with or without a diagnosis of ASD, with IQ ranging from 60-150.
Clinical Trials Government Identifier
NCT05294705
Does this study also recruit healthy volunteers?
No